Long-term results of 60 patients with pathologic stage I and IIA Hodgkin's disease treated with exclusive mantle radiation therapy

European Journal of Haematology

Volumn 63, Issue 2, 1999, Pages 126-133

  Maurizi Enrici, Riccardo ^a   Osti, Mattia Falchetto ^a   Zurlo, Alfredo ^a   Anselmo, Anna Paola ^a   Lacari, Valter ^a   Mandelli, Franco ^a  

^a NONE

Author keywords

Early stage Hodgkin's disease; Exclusive radiotherapy; Mantle radiation therapy; Radiation therapy late effects; Surgical staging

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MANTLE FIELD RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0032795918     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01126.x     Document Type: Article

References (34)

1. 1. GANESAN TS, OZA A, PERRY N, et al. Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital. Ann Oncol 1992: 3: 349-356.
2. 2. HARTSELL WF, SARIN P, RECINE DC, et al. Long-term results of curative irradiation in pathologically staged IA and IIA Hodgkin Disease. Radiology 1993: 186: 565-568.
3. 3. HOPPE RT, COLEMAN NC, COX RS, ROSENBERG SA, KAPLAN HS. The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood 1982: 59: 455-465.
4. 4. ZAGARS G, RUBIN P. Laparatomy-staged I versus IIA Hodgkin's disease: A comparative study with evaluation of prognostic factors for stage IIA disease. Cancer 1985: 56: 864-873.
5. 5. BRUSAMOLINO E, LAZZARINO M, ORLANDI E, et al. Early stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Ann Oncol 1996: 5: S101-S106.
6. 6. MAUCH PM, TARBEL N, WEINSTEIN H, et al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 1988: 6: 1576-1583.
7. 7. TUBIANA M, HENRY-AMAR M, CARDE P, et al. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma group controlled clinical trials: 1964 1987. Blood 1989: 73: 47-56.
8. 8. MANDELLI F, ANSELMO AP, CARTONI C, CIMINO G, MAURIZI ENRICI R, BIAGINI C. Evaluation of therapeutic modalities in the control of Hodgkin's disease. Int J Rad Oncol Biol Phys 1986: 12: 1671-1680.
9. 9. MAUCH PM. Controversies in the management of early stage Hodgkin's disease. Blood 1994: 83: 318-329.
10. 10. ROACH III M, BROPHY N, Cox R, VARGHESE A, HOPPE RT. Prognostic factor for patients relapsing after radiotherapy for early-stage Hodgkin's disease. J Clin Oncol 1990: 8: 623-629.
11. 11. SPECHT L, NORDENTOFT AM, COLD S, CLAUSE NT, NISSEN NI. Tumour burden in early stage Hodgkin's disease. The single most important prognostic factor for outcome after radiotherapy. Br J Cancer 1987: 55: 533-539.
12. 12. ANSELMO AP, BOVE MT, CARTONI C, MAURIZI ENRICI R, OSTI MF. Combined modality (ABVD plus Radio-therapy) versus Radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement. Haematology 1992: 77: 1-3.
13. 13. BONFANTE V, SANTORO A, VIVIANI S. Early stage Hodgkin's disease: Ten-yr results of a non-randomised study with radiotherapy alone or combined with MOPP. Eur J Cancer 1993: 29: 24-29.
14. 14. DE VITA VT. Hodgkin's disease: the salvage of radiation treatment failures. Int J Radiat Oncol Biol Phys 1977: 2: 86-93.
15. 15. HOPPE RT. Early stage Hodgkin's disease: A choice of treatments or a treatment of choice? J Clin Oncol 1991: 9: 897-901.
16. 16. SPECHT L, HORWICH A, ASHLEY S. Salvage of relapse of patients with Hodgkin's disease in clinical stages I or II who were staged with laparotomy and initially treated with radiotherapy alone. A report from the international database on Hodgkin's disease. Int J Radiat Oncol Biol Phys 1994: 30: 805-811.
17. 17. CIMINO G, PAPA G, TURA S. Secondary primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study. J Clin Oncol 1991: 9: 432-437.
18. 18. COSSET JM, HENRY AMAR M, MEERWALDT JH. Long-term toxicity of early stage of Hodgkin's disease therapy: the EORTC experience. Ann Oncol 1991: 2: 77-82.
19. 19. HENRY-AMAR M, HAYAT M, MEERWALDT JH, et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. Int J Radiat Oncol Biol Phys 1990: 19: 1155-1157.
20. 20. KALDOR JM, DAY NE, CLARKE EA. Leukemia following Hodgkin's disease. N Engl J Med 1990: 322: 7-13.
21. 21. KINSELLA TJ, TRIVETTE G, ROLAND J, et al. Long-term follow-up of testicular function following radiation therapy for early stage Hodgkin's disease. J Clin Oncol 1989: 7: 718-724.
22. 22. PAPA G, MAURO G, ANSELMO AP, et al. Acute leukaemia in patients treated for Hodgkin's disease. Br J Haematol 1984: 58: 43-52.
23. 23. RODRIGUEZ MA, FULLER LM, ZIMMERMAN SO, et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol 1993: 4: 125-131.
24. 24. TUCKER MA, COLEMAN CN, BOX RS, VARGHESE A, ROSEMBERG SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988: 318: 76-80.
25. 25. CARBONE PP, KAPLAN HS, MUSSHOFFS K, SIUTHERS DW, TUBIANA M. Report of the committee on Hodgkin's disease. Staging classification. Cancer Res 1971: 18: 60-61.
26. 26. BIAGINI C, MAURIZI ENRICI R, ANSELMO AP, BANELLI E, CIMINO G, OSTI MF. The role of restaging laparotomy in Hodgkin's disease. Acta Oncol 1989: 28: 659-662.
27. 27. KAPLAN ES, MEIER P. Non parametric estimation from incomplete observations. Am Stat Assoc 1958: 53: 457-480.
28. 28. Cox DR. Regression models and life tables. J R Stat Soc B 1972: 34: 187-220.
29. 29. BODIS S, HENRY-AMAR M, BOSQ J, et al. Late relapse in earlystage Hodgkin's disease patients enrolled on on european organization for research and treatment of cancer protocols. J Clin Oncol 1993: 112: 225-232.
30. 30. TATE DJ, HOPPE RT. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease. An analysis of risk, management and outcome. Int J Radiat Oncol Biol Phys 1995: 32: 1239-1244.
31. 31. LEE KKC, LEVITT SH. Curative radiotherapy is the best single treatment modality for the favorable early stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1994: 30: 1003-1005.
32. 32. GOSPODAROWICZ MK, SUTCLIFFE SB, CLARK RM. Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys 1992: 23: 859-865.
33. 33. SCHEWE KL, REAVIS J, KUN LE, COX JD. Total dose, fraction size, and tumour volume in the local control of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1988: 15: 25-28.
34. 34. JOCKOVICH M, MENDENHALL NP, SOMBECK MD, et al. Long-term complications of laparatomy in Hodgkin's disease. Int J Radiat Oncol Biol Phys 1994: 30: 615-624.